NORTH AMERICA HYDROCORTISONE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

North America Hydrocortisone Market, By Type (Branded and Generics), By Route of Administration (Parenteral, Oral, and Topical), By Acute Care Indication (Sepsis and Septic Shock, Adrenal Crisis and Peri-operative Stress-dose Steroids, Acute Asthma/COPD Exacerbations, Severe Allergic Reactions and Anaphylaxis, Neuro/Trauma, and Others), By End User (Acute Care Hospitals, Hospital-based Outpatient Clinics and Infusion Centers, Community Clinics and Urgent Care Centers, Retail / Community Care, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

Published In: 10 Apr, 2026
Code: CMI9430
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

The North America hydrocortisone market is estimated to be valued at USD 82,925.8 Mn in 2026 and is expected to reach USD 162,787.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033. The North America hydrocortisone market represents a major sector of the pharmaceutical industry due to the growing demand for hydrocortisone products as topical steroid drugs used in the treatment of various inflammatory skin conditions, allergies, and other skin diseases, such as eczema, dermatitis, and psoriasis. Hydrocortisone drugs can be presented in different forms, namely, creams, ointments, lotions, gels, and sprays, and possess various strengths, ranging from OTC to prescription.

The market is primarily promoted by an increased occurrence of skin problems, enhanced awareness about dermatological diseases, and availability of OTC drugs, especially in the countries of the U.S., and Canada. Additionally, growth of the population, increased spending on healthcare services, and innovations in manufacturing of drugs promote the expansion of the pharmaceutical sector.

Market Dynamics

The North America hydrocortisone market is fueled by an increase in the incidences of various chronic skin diseases, such as eczema, atopic dermatitis, and psoriasis, among other ailments. Additionally, the market can be attributed to increasing exposure to environmental factors, greater awareness levels about skin conditions, and increased access to medical facilities. The increased availability of over-the-counter hydrocortisone and disposable income will help in driving the growth in the market segment.

Nevertheless, some of the limitations in this market include regulatory policies governing the use of corticosteroids, possible side effects due to long-term use such as thinning of skin and drug dependency, and an emerging trend among consumers towards natural or organic drugs. Generic drug rivalry is also likely to keep the prices low.

However, the market has promising prospects with innovations in terms of new methods of drug administration, formulation of more efficient drugs, and exploring more uses of the product. With the development of telemedicine services, more combination and personalized therapy treatments, as well as pediatric and veterinary dermatology becoming more popular, there are bound to be more areas of growth in the market.

Key Features of the Study

This report provides in-depth analysis of the North America hydrocortisone market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the North America hydrocortisone market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Johnson & Johnson, Bayer AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The North America hydrocortisone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America hydrocortisone market

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generics
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Parenteral
- Oral
- Topical
Acute Care Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Sepsis and Septic Shock
- Adrenal Crisis and Peri-operative Stress-dose Steroids.
- Acute Asthma/COPD Exacerbations
- Severe allergic reactions and anaphylaxis
- Neuro/Trauma
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Acute Care Hospitals
- Hospital-based outpatient clinics and Infusion Centers
- Community Clinics and Urgent Care Centers
- Retail / community care
- Others
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Key Players Insights
- Pfizer Inc.
- Johnson & Johnson
- Bayer AG
- GlaxoSmithKline plc
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Novartis AG

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - North America Hydrocortisone Market, By Type
  - North America Hydrocortisone Market, By Route of Administration
  - North America Hydrocortisone Market, By Acute Care Indication
  - North America Hydrocortisone Market, By End User
  - North America Hydrocortisone Market, By Distribution Channel
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
North America Hydrocortisone Market, By Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Branded
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
North America Hydrocortisone Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Parenteral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
North America Hydrocortisone Market, By Acute Care Indication, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Sepsis and Septic Shock
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Adrenal Crisis and Peri-operative Stress-dose Steroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Acute Asthma/COPD Exacerbations
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Severe Allergic Reactions and Anaphylaxis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neuro/Trauma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
North America Hydrocortisone Market, By End User, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Acute Care Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hospital-based Outpatient Clinics and Infusion Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Community Clinics and Urgent Care Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail / Community Care
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
North America Hydrocortisone Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Competitive Landscape
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Viatris Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hikma Pharmaceuticals PLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Hydrocortisone Market’– North America forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now